Kleine-Levin Syndrome: Symptoms, Diagnosis, and Care

Kleine-Levin syndrome (KLS) is a rare central disorder of hypersomnolence. It causes separate episodes of severe sleepiness and increased sleep, together with changes in thinking, perception, motivation, or behavior. The person is usually back at or near their usual baseline between episodes, especially early in the course of the condition ¹.

KLS is not simply sleeping for a long time. A person who regularly sleeps late, has persistent daytime sleepiness, or needs more sleep after an illness does not necessarily have it. The recurrent pattern and the changes that occur while awake are central to the diagnosis.

The nickname "Sleeping Beauty syndrome" appears in popular coverage, but it can make a disabling neurologic condition sound harmless or passive. Kleine-Levin syndrome or KLS is clearer and more respectful.

What a KLS episode can look like

An episode may begin abruptly. The person sleeps much longer than usual or repeatedly returns to sleep, yet may still seem exhausted when awake. Some people spend most of the day asleep. Others spend part of the time lying quietly with their eyes closed while an EEG shows that they are awake. A fixed number of sleep hours is therefore not a diagnostic requirement ².

Changes while awake can be as important as the sleepiness:

• Cognitive slowing or confusion: Speech and responses may be slow. Attention, memory, reading, decision-making, and sense of time can be impaired.
• Derealization: The surroundings may feel unreal, distant, dreamlike, or visually altered even though the person is awake.
• Major apathy: A person may stop initiating conversation, using their phone, attending to hygiene, eating, or engaging with people and activities they normally value.
• Irritability or distress: Attempts to keep the person awake may lead to frustration or agitation.
• Behavior or appetite changes: Some people eat more, eat less, act impulsively, or show sexual disinhibition. Hyperphagia and hypersexuality are not required for KLS, and they do not occur in every episode.
• Mood or perceptual symptoms: Anxiety, low mood, hallucinations, or delusional ideas can occur, but a new psychiatric symptom still needs assessment rather than automatic attribution to KLS ¹².

Symptoms can differ from one episode to the next. KLS often begins in adolescence, and boys and young men are overrepresented in clinical cohorts, but it can affect girls and women and can begin in younger children or adults. An unusual age, a prolonged episode, or an incomplete recovery does not by itself settle the diagnosis. It makes a careful search for alternatives especially important ¹³.

Current diagnostic criteria

The current International Classification of Sleep Disorders, Third Edition, Text Revision (ICSD-3-TR) requires all of the following:

1. At least two recurrent episodes of excessive sleepiness and increased sleep duration, each lasting from two days to several weeks.
2. Episodes that usually occur more than once a year and at least once every 18 months.
3. Normal or near-normal sleep and wakefulness, cognition, behavior, and mood between episodes, at least during the early years of the condition.
4. At least one of these during an episode: cognitive dysfunction, derealization, major apathy, or disinhibited behavior such as hyperphagia or hypersexuality.
5. No better explanation from chronic insufficient sleep, a circadian rhythm disorder, another sleep disorder, a medical or neurologic condition, a mental disorder, or medication or substance use or withdrawal ¹.

The criteria explain why KLS cannot be established from one episode of prolonged sleepiness. A first episode should be treated as unexplained altered alertness and behavior until urgent causes have been assessed. They also show why the familiar trio of sleep, overeating, and hypersexuality is misleading. Neither eating more nor sexual disinhibition is mandatory.

The older phrase "secondary KLS" should not be used as a shortcut when a brain injury, neurologic disease, medication, or another condition better explains the episodes. Current criteria require the alternative cause to be recognized rather than folded into KLS ¹.

Many people appear close to their prior baseline between episodes, but "normal between episodes" should not be treated as a guarantee. In a controlled cohort, some patients had slower processing, attention problems, or difficulty retrieving verbal memories during apparently asymptomatic periods. Persistent cognitive, mood, or sleep changes deserve reassessment and practical school or work support ⁴.

How clinicians distinguish KLS from other conditions

Diagnosis rests on the pattern over time, collateral observations, and exclusion of better explanations. Conditions that can resemble part of a KLS episode include:

• medication effects, intoxication, overdose, or substance withdrawal
• chronic sleep deprivation, circadian misalignment, obstructive sleep apnea, narcolepsy, and idiopathic hypersomnia
• depression, bipolar disorder, psychosis, catatonia, and other mental health conditions
• seizures, encephalitis or other brain inflammation, migraine, head injury, and structural brain disease
• metabolic or systemic problems such as abnormal glucose or electrolytes, thyroid disease, and liver or kidney dysfunction

Persistent daily sleepiness is more typical of insufficient sleep, narcolepsy, idiopathic hypersomnia, or another ongoing sleep or medical problem than of a relapsing-remitting KLS pattern. Bipolar disorder can also be episodic, so clinicians look closely at sleep need, mood, energy, thought speed, behavior, and what returns to baseline between events. In a specialist series of people referred with possible KLS, psychiatric conditions were among the most frequent alternative diagnoses ³.

A relative, partner, or other observer can provide details the person does not remember. A short episode record can capture:

• the start and end of the change
• estimated sleep and awake periods
• confusion, derealization, apathy, speech, behavior, appetite, and mood
• medicines, supplements, alcohol, cannabis, or other substances
• recent illness, injury, travel, missed sleep, stress, and menstrual timing when relevant
• fluid intake, urination, falls, or other safety problems
• the person's function before and after the episode

A phone video may help a clinician understand speech, movement, or responsiveness, provided recording is safe and respects the person's privacy. It cannot diagnose KLS.

Tests are chosen to answer specific questions

There is no blood test, brain scan, EEG pattern, or sleep-study result that confirms KLS. A clinician may select tests according to the presentation:

• Blood and urine testing can look for metabolic illness, infection, endocrine problems, or medication and substance exposure.
• EEG can investigate a possible seizure or an unexplained change in responsiveness. Nonspecific slowing can occur during KLS episodes, but it is not a KLS signature.
• MRI or other brain imaging may be appropriate after an injury or when there are focal neurologic signs, severe headache, an atypical course, or concern about a structural cause.
• Lumbar puncture and infection or immune testing are reserved for presentations that raise concern about meningitis, encephalitis, or another inflammatory condition.
• Polysomnography can assess sleep apnea or another sleep disorder when the history points that way. A multiple sleep latency test may be used in an evaluation for narcolepsy or idiopathic hypersomnia, but normal and abnormal results have both been reported in KLS ².

Structural imaging is usually normal in people diagnosed with KLS. Research studies have found group-level differences on functional imaging and experimental protein testing, but these findings vary and are not validated clinical diagnostic biomarkers ².

What causes KLS?

The cause is unknown. Hypothalamic, thalamic, immune, inflammatory, genetic, metabolic, and circadian explanations are being studied, but none has been proved to account for KLS in an individual. Functional changes involving the hypothalamus do not establish that hypothalamic injury caused the condition ².

Families sometimes report an infection, alcohol use, missed sleep, stress, travel, or another event before an episode. These are temporal observations, not proof that the event caused the episode. An episode diary may reveal a useful personal pattern, but no avoidance routine has been shown to prevent KLS reliably ¹.

Managing an established episode

A person with diagnosed KLS should have an episode plan agreed with their sleep or neurology specialist. A familiar episode that follows that plan may often be managed at home, but a first episode, a changed pattern, or a new concerning symptom needs medical reassessment.

During an established episode:

• Provide a quiet, familiar place to sleep and reduce nonessential demands. Do not repeatedly force the person to stay awake.
• Arrange responsible supervision. Altered memory, perception, and judgment can make ordinary activities unsafe.
• Do not allow driving, cycling in traffic, machinery use, cooking over heat, swimming alone, unsupervised bathing, work at heights, or other high-consequence activity.
• Offer fluids and simple meals when the person is awake. Keep track of drinking, swallowing, urination, vomiting, and significant changes in intake.
• Give calm prompts for toileting, hygiene, and prescribed medicines when needed. Do not start extra sedatives, stimulants, supplements, or other treatments without the clinical team's direction.
• Notify school or work and use the established absence and return plan. Delay examinations, contracts, financial decisions, and other high-stakes tasks while cognition is altered.
• Monitor for depression, self-harm thoughts, psychosis, aggression, or sexual disinhibition. Protect the person and others without shaming behavior that occurred during impaired awareness ².

Return to driving, school, work, sports, or independent care should depend on recovery of alertness, judgment, and function, not simply the calendar date. Lingering cognitive problems may justify a gradual return or temporary accommodations ⁴.

What medication evidence shows

No medication is a proven cure, and no drug has high-certainty evidence that it ends or prevents KLS episodes. A Cochrane review found no randomized or quasi-randomized treatment trials, so reports of benefit are difficult to separate from the condition's naturally changing course ⁵.

Wake-promoting stimulants are sometimes considered during an episode. They may increase wakefulness for some people, but they have not been shown to restore normal cognition or prevent future episodes and can aggravate irritability or agitation. This is a specialist decision, not a reason to use someone else's stimulant or increase a prescribed dose independently ²⁵.

The American Academy of Sleep Medicine gives a conditional recommendation for clinicians to consider lithium rather than no treatment in adults with KLS. The evidence was judged very low certainty and came mainly from one prospective, open-label, single-center study. In that cohort, patients taking lithium improved more than an untreated group on episode frequency and duration, but treatment was not randomized and the groups differed before treatment ⁶⁷.

Lithium has a narrow safety margin. It requires serum-level and kidney, thyroid, electrolyte, and other clinical monitoring. Dehydration, fever, vomiting, diarrhea, major changes in activity, and medicines such as some anti-inflammatory drugs, diuretics, ACE inhibitors, and related blood-pressure drugs can change lithium levels or toxicity risk. Anyone taking it needs a prescriber-specific illness and interaction plan. Contact the prescriber promptly when one of these situations occurs, follow the agreed instructions, and do not improvise a dose change ⁸.

New or worsening vomiting, diarrhea, coarse tremor, slurred speech, poor coordination, or confusion while taking lithium needs urgent medical or poison-control advice because these can be toxicity signs ⁸.

Evidence for anticonvulsants, antidepressants, antipsychotics, steroids, and other proposed treatments is also insufficient to promise episode control. Decisions should reflect episode burden, age, pregnancy potential, other health conditions, side effects, monitoring, and the person's priorities ⁶⁵.

When to seek urgent or emergency care

Seek urgent same-day medical assessment for a first suspected episode, a substantially longer or different episode, incomplete recovery, a new medicine or substance exposure, or a new neurologic or psychiatric symptom. KLS should not be used to explain away an unfamiliar change.

Call emergency services if the person:

• cannot be roused in their usual way, has abnormal or difficult breathing, or turns blue or gray
• has a seizure, new weakness, severe imbalance, or another sudden focal neurologic change
• has fever with severe headache, stiff neck, marked confusion, or rapidly worsening responsiveness
• may have taken an overdose, poison, or unknown substance
• cannot swallow safely, cannot keep fluids down, urinates very little, or shows severe dehydration
• has severe agitation, dangerous behavior, psychosis, or thoughts or actions involving self-harm or harm to someone else

Even with an established KLS diagnosis, these signs require assessment for infection, seizure, metabolic illness, toxicity, and other emergencies rather than routine home observation ¹³.

Living between episodes

Follow-up should review the episode record, recovery, medication safety, mood, cognition, school or work effects, and the current driving plan. Children and teenagers may need written attendance flexibility, adjusted deadlines, tutoring, or a gradual academic return. Adults may need episodic medical leave or temporary task restrictions.

Episodes often become less frequent or eventually stop, but there is no reliable timetable for an individual. A fixed number of attacks or a guaranteed decade-long course is not supported. Ongoing sleepiness, cognitive change, mood symptoms, or behavior change between episodes should trigger reassessment rather than being accepted as inevitable KLS ³⁴.